Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation

Sita Bhella, Navneet S. Majhail, Jeffrey Betcher, Luciano J. Costa, Andrew Daly, Christopher E. Dandoy, Zachariah DeFilipp, Vi Doan, Alison Gulbis, Lisa Hicks, Mark Juckett, Nandita D Khera, Amrita Krishnan, George Selby, Nirav N. Shah, Melisa Stricherz, Auro Viswabandya, Christopher Bredeson, Matthew D. Seftel

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Choosing Wisely encourages dialogue about reducing unnecessary procedures, tests, or treatments in healthcare. The American Society for Blood and Marrow Transplantation (ASBMT) and Canadian Blood and Marrow Transplant Group (CBMTG) established a Choosing Wisely BMT Task Force whose objective was to create a list of top 5 practices in blood and marrow transplantation to be questioned. The Task Force consisted of representatives from ASBMT's Quality Outcomes, Education, and Practice Guidelines committees; ASBMT's Pharmacy Special Interest Group; CBMTG Program Directors; and Center for International Blood and Marrow Transplant Research (CIBMTR). Suggestions for current transplantation practices to question were elicited from the CBMTG Program Directors; members of ASBMT's Quality Outcomes, Practice Guidelines, and Education committees; and chairs of the CIBMTR scientific working committees. We received 119 unique suggestions that were ranked based on their potential impact on harm reduction, cost reduction, necessity of the test or practice, and the strength of available evidence. Through a modified Delphi process, suggestions were narrowed down to 6, which were then subjected to systematic reviews. The final 5 recommendations focus on graft source for patients with aplastic anemia, corticosteroid dose for initial treatment of graft-versus-host-disease, optimal number of umbilical cord blood units for transplantation, graft source in matched unrelated donor transplantation, and use of prophylactic intravenous immunoglobulin in transplant recipients. These Choosing Wisely BMT recommendations are relevant to the current clinical practice of blood and marrow transplantation and focus on tests, treatments, or procedures that may be harmful, wasteful, or for which there is no apparent clinical benefit.

Original languageEnglish (US)
JournalBiology of Blood and Marrow Transplantation
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Transplantation
Bone Marrow
Transplants
Advisory Committees
Practice Guidelines
Therapeutics
Harm Reduction
Unnecessary Procedures
Education
Unrelated Donors
Public Opinion
Aplastic Anemia
Intravenous Immunoglobulins
Graft vs Host Disease
Fetal Blood
Research
Adrenal Cortex Hormones
Delivery of Health Care
Costs and Cost Analysis

Keywords

  • Allogeneic
  • Autologous
  • Choosing wisely
  • Hematopoietic stem cell transplantation
  • Quality of care
  • Transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Choosing Wisely BMT : American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation. / Bhella, Sita; Majhail, Navneet S.; Betcher, Jeffrey; Costa, Luciano J.; Daly, Andrew; Dandoy, Christopher E.; DeFilipp, Zachariah; Doan, Vi; Gulbis, Alison; Hicks, Lisa; Juckett, Mark; Khera, Nandita D; Krishnan, Amrita; Selby, George; Shah, Nirav N.; Stricherz, Melisa; Viswabandya, Auro; Bredeson, Christopher; Seftel, Matthew D.

In: Biology of Blood and Marrow Transplantation, 01.01.2018.

Research output: Contribution to journalArticle

Bhella, S, Majhail, NS, Betcher, J, Costa, LJ, Daly, A, Dandoy, CE, DeFilipp, Z, Doan, V, Gulbis, A, Hicks, L, Juckett, M, Khera, ND, Krishnan, A, Selby, G, Shah, NN, Stricherz, M, Viswabandya, A, Bredeson, C & Seftel, MD 2018, 'Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation', Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2018.01.017
Bhella, Sita ; Majhail, Navneet S. ; Betcher, Jeffrey ; Costa, Luciano J. ; Daly, Andrew ; Dandoy, Christopher E. ; DeFilipp, Zachariah ; Doan, Vi ; Gulbis, Alison ; Hicks, Lisa ; Juckett, Mark ; Khera, Nandita D ; Krishnan, Amrita ; Selby, George ; Shah, Nirav N. ; Stricherz, Melisa ; Viswabandya, Auro ; Bredeson, Christopher ; Seftel, Matthew D. / Choosing Wisely BMT : American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation. In: Biology of Blood and Marrow Transplantation. 2018.
@article{d668b612aa044c5d979b7be472925a5b,
title = "Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation",
abstract = "Choosing Wisely encourages dialogue about reducing unnecessary procedures, tests, or treatments in healthcare. The American Society for Blood and Marrow Transplantation (ASBMT) and Canadian Blood and Marrow Transplant Group (CBMTG) established a Choosing Wisely BMT Task Force whose objective was to create a list of top 5 practices in blood and marrow transplantation to be questioned. The Task Force consisted of representatives from ASBMT's Quality Outcomes, Education, and Practice Guidelines committees; ASBMT's Pharmacy Special Interest Group; CBMTG Program Directors; and Center for International Blood and Marrow Transplant Research (CIBMTR). Suggestions for current transplantation practices to question were elicited from the CBMTG Program Directors; members of ASBMT's Quality Outcomes, Practice Guidelines, and Education committees; and chairs of the CIBMTR scientific working committees. We received 119 unique suggestions that were ranked based on their potential impact on harm reduction, cost reduction, necessity of the test or practice, and the strength of available evidence. Through a modified Delphi process, suggestions were narrowed down to 6, which were then subjected to systematic reviews. The final 5 recommendations focus on graft source for patients with aplastic anemia, corticosteroid dose for initial treatment of graft-versus-host-disease, optimal number of umbilical cord blood units for transplantation, graft source in matched unrelated donor transplantation, and use of prophylactic intravenous immunoglobulin in transplant recipients. These Choosing Wisely BMT recommendations are relevant to the current clinical practice of blood and marrow transplantation and focus on tests, treatments, or procedures that may be harmful, wasteful, or for which there is no apparent clinical benefit.",
keywords = "Allogeneic, Autologous, Choosing wisely, Hematopoietic stem cell transplantation, Quality of care, Transplantation",
author = "Sita Bhella and Majhail, {Navneet S.} and Jeffrey Betcher and Costa, {Luciano J.} and Andrew Daly and Dandoy, {Christopher E.} and Zachariah DeFilipp and Vi Doan and Alison Gulbis and Lisa Hicks and Mark Juckett and Khera, {Nandita D} and Amrita Krishnan and George Selby and Shah, {Nirav N.} and Melisa Stricherz and Auro Viswabandya and Christopher Bredeson and Seftel, {Matthew D.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.bbmt.2018.01.017",
language = "English (US)",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Choosing Wisely BMT

T2 - American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation

AU - Bhella, Sita

AU - Majhail, Navneet S.

AU - Betcher, Jeffrey

AU - Costa, Luciano J.

AU - Daly, Andrew

AU - Dandoy, Christopher E.

AU - DeFilipp, Zachariah

AU - Doan, Vi

AU - Gulbis, Alison

AU - Hicks, Lisa

AU - Juckett, Mark

AU - Khera, Nandita D

AU - Krishnan, Amrita

AU - Selby, George

AU - Shah, Nirav N.

AU - Stricherz, Melisa

AU - Viswabandya, Auro

AU - Bredeson, Christopher

AU - Seftel, Matthew D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Choosing Wisely encourages dialogue about reducing unnecessary procedures, tests, or treatments in healthcare. The American Society for Blood and Marrow Transplantation (ASBMT) and Canadian Blood and Marrow Transplant Group (CBMTG) established a Choosing Wisely BMT Task Force whose objective was to create a list of top 5 practices in blood and marrow transplantation to be questioned. The Task Force consisted of representatives from ASBMT's Quality Outcomes, Education, and Practice Guidelines committees; ASBMT's Pharmacy Special Interest Group; CBMTG Program Directors; and Center for International Blood and Marrow Transplant Research (CIBMTR). Suggestions for current transplantation practices to question were elicited from the CBMTG Program Directors; members of ASBMT's Quality Outcomes, Practice Guidelines, and Education committees; and chairs of the CIBMTR scientific working committees. We received 119 unique suggestions that were ranked based on their potential impact on harm reduction, cost reduction, necessity of the test or practice, and the strength of available evidence. Through a modified Delphi process, suggestions were narrowed down to 6, which were then subjected to systematic reviews. The final 5 recommendations focus on graft source for patients with aplastic anemia, corticosteroid dose for initial treatment of graft-versus-host-disease, optimal number of umbilical cord blood units for transplantation, graft source in matched unrelated donor transplantation, and use of prophylactic intravenous immunoglobulin in transplant recipients. These Choosing Wisely BMT recommendations are relevant to the current clinical practice of blood and marrow transplantation and focus on tests, treatments, or procedures that may be harmful, wasteful, or for which there is no apparent clinical benefit.

AB - Choosing Wisely encourages dialogue about reducing unnecessary procedures, tests, or treatments in healthcare. The American Society for Blood and Marrow Transplantation (ASBMT) and Canadian Blood and Marrow Transplant Group (CBMTG) established a Choosing Wisely BMT Task Force whose objective was to create a list of top 5 practices in blood and marrow transplantation to be questioned. The Task Force consisted of representatives from ASBMT's Quality Outcomes, Education, and Practice Guidelines committees; ASBMT's Pharmacy Special Interest Group; CBMTG Program Directors; and Center for International Blood and Marrow Transplant Research (CIBMTR). Suggestions for current transplantation practices to question were elicited from the CBMTG Program Directors; members of ASBMT's Quality Outcomes, Practice Guidelines, and Education committees; and chairs of the CIBMTR scientific working committees. We received 119 unique suggestions that were ranked based on their potential impact on harm reduction, cost reduction, necessity of the test or practice, and the strength of available evidence. Through a modified Delphi process, suggestions were narrowed down to 6, which were then subjected to systematic reviews. The final 5 recommendations focus on graft source for patients with aplastic anemia, corticosteroid dose for initial treatment of graft-versus-host-disease, optimal number of umbilical cord blood units for transplantation, graft source in matched unrelated donor transplantation, and use of prophylactic intravenous immunoglobulin in transplant recipients. These Choosing Wisely BMT recommendations are relevant to the current clinical practice of blood and marrow transplantation and focus on tests, treatments, or procedures that may be harmful, wasteful, or for which there is no apparent clinical benefit.

KW - Allogeneic

KW - Autologous

KW - Choosing wisely

KW - Hematopoietic stem cell transplantation

KW - Quality of care

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85044666234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044666234&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2018.01.017

DO - 10.1016/j.bbmt.2018.01.017

M3 - Article

C2 - 29360515

AN - SCOPUS:85044666234

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

ER -